-
-
Toggle navigation
Frontiers journals are at the top of citation and impact metrics
Scope
Frontiers in Pharmacology is a leading journal in its field, publishing rigorously peer-reviewed research across disciplines, including basic and clinical pharmacology, medicinal chemistry, pharmacy and toxicology.
Read more
Scope & Mission
Frontiers in Pharmacology is a leading journal in its field, publishing rigorously peer-reviewed research across disciplines, including basic and clinical pharmacology, medicinal chemistry, pharmacy and toxicology. Field Chief Editor Heike Wulff at UC Davis is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
Pharmacology is a medical science, as was recalled in the anniversary address for the 50th Spring Meeting in Mainz of the German Pharmacological Society in March 2009. This science, of the effect of medicinal bodies, gives us the handle to clarify the fundamental processes of life. It is also the science studying the interactions between chemicals and living beings directed to prevent, ameliorate or cure the deleterious consequences of their diseases, thereby it provides medicine with weapons against diseases. Those major targets offer the opportunity to segment the field not only in studies considering pure basic topics but also by integrating basic and clinical science. This journal's editorial policy aims at identifying the most productive research projects through an evaluation by the scientific community and emphasizing proper use of translational science at both preclinical and clinical levels. Editors encourage collaboration between clinicians and basic scientists and welcome papers issued from a collaborative strategy between the academic and the private industrial sectors that could benefit to the reversal of the current decline in the production of original medicines.
Frontiers in Pharmacology is a member of the Committee on Publication Ethics.
Frontiers in Pharmacology generally endorses the principles described in the 4 pillars of ethnopharmacology for all studies involving natural products submitted to all specialty sections in the journal
Founding Field Chief Editor: Prof Theophile Godfraind
Short Name: Front. Pharmacol.
Abbreviation: fphar
Electronic ISSN: 1663-9812
Indexed in: PubMed, PubMed Central, Scopus, Web of Science, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS)
PMCID: all published articles receive a PMCID
Submission
Frontiers in Pharmacology is composed of the following Specialty Sections:
The specialty sections of Frontiers in Pharmacology welcome submission of the following article types: Book Review, Brief Research Report, Case Report, Clinical Trial, Correction, Data Report, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Protocols, Review, Specialty Grand Challenge, Systematic Review, Technology Report, Research Snapshot, Erratum, Clinical Study Protocol, Policy and Practice Reviews, Curriculum, Instruction, and Pedagogy and Policy Brief.
When submitting a manuscript to Frontiers in Pharmacology, authors must submit the material directly to one of the specialty sections. Manuscripts are peer-reviewed by the Associate and Review Editors of the respective specialty section.
Articles published in the specialty sections above will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in the Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Pharmacology.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
-
- All sections
- Cancer Molecular Targets and Therapeutics
- Cardiovascular and Smooth Muscle Pharmacology
- Drug Metabolism and Transport
- ELSI in Science and Genetics
- Ethnopharmacology
- Experimental Pharmacology and Drug Discovery
- Gastrointestinal and Hepatic Pharmacology
- Inflammation Pharmacology
- Integrative and Regenerative Pharmacology
- Neuropharmacology
- Obstetric and Pediatric Pharmacology
- Pharmaceutical Medicine and Outcomes Research
- Pharmacogenetics and Pharmacogenomics
- Pharmacology of Anti-Cancer Drugs
- Pharmacology of Ion Channels and Channelopathies
- Predictive Toxicology
- Renal Pharmacology
- Respiratory Pharmacology
- Translational Pharmacology
- Editor(s) found
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This journal has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01